The company is developing a new genome-modulation tool that can overcome the limitations of current technologies, with the goal of creating new therapeutic options for patients with rare diseases. Pencil Biosciences' innovative platform has the potential to have a wide impact across a range of applications, helping medical professionals to overcome the challenges of gene editing. By developing a programmable genome-modulation tool, the company is poised to make a significant contribution to the field of gene therapy.